Imatinib Completed Phase 1 / 2 Trials for Leukemia, Myelogenous, Chronic, BCR-ABL Positive Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs